Virus News and Research

Latest Virus News and Research

Breast milk components show potent in vitro SARS-CoV-2 inhibition

Human breastmilk contains substances that can inhibit infection by SARS-CoV-2 and its variants, as well as prevent its replication.

24 Mar 2022

New implantable biotechnology produces and releases CAR-T cells for attacking tumors

Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed an implantable biotechnology that produces and releases CAR-T cells for attacking cancerous tumors.

24 Mar 2022

U of A researcher receives $436,642 from NIH to study effects of SARS-COV-2 on the aortic valve

The National Institute of Health awarded $436,642 to associate professor of biomedical engineering, Kartik Balachandran, to study the downstream effects of acute respiratory syndrome coronavirus 2 on the aortic valve.

24 Mar 2022

Polio vaccination campaign kicks off in Malawi and neighboring countries

A vaccination campaign targeting 23 million children has kicked off in Malawi and neighboring countries to contain an outbreak of wild polio declared last month, the World Health Organization says.

24 Mar 2022

UB-612 vaccine booster found to elicit high neutralizing antibody levels against SARS-CoV-2 Omicron

Researchers evaluated the effectiveness of a novel vaccine candidate UB-612 against 14 SARS-CoV-2 variants, including the latest variant of concern, Omicron.

24 Mar 2022

Study explores favorable signatures for specific RNA motif recognition by SARS-CoV-2 nucleocapsid

A new study evaluated the N terminal domain of the SARS-CoV-2 nucleocapsid protein. It presented the targeted characteristics for selective ribonucleic acid identification by SARS-CoV-2 N in its 5'-genomic end.

24 Mar 2022

New SARS-CoV-2 Omicron-Delta recombinant virus identified in the US

Researchers reported a novel SARS-CoV-2 Omicron and Delta recombinant virus in the United States.

24 Mar 2022

Study evaluates mutation-induced SARS-CoV-2 spike protein fold stability

Researchers evaluated the stability and expression of mutations in the spike protein of SARS-CoV-2.

24 Mar 2022

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

A recent study demonstrated that RNA interference could prophylactically protect against SARS-CoV-2.

24 Mar 2022

Study evaluates the prevalence of autoantibodies targeting type I interferons in critically-ill COVID-19 patients

Researchers assessed the prevalence of antibodies that neutralize the type I interferon antiviral activity and reactivate herpesviruses such as herpes simplex virus types 1 and 2 and/or cytomegalovirus infections in patients with critical COVID-19.

24 Mar 2022

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

For World Tuberculosis Day 2022, News Medical spoke to Dr. Maxine Caws to raise awareness of this infectious disease.

24 Mar 2022

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

Scientists from the United States have recently assessed the evolutionary success of mutations accumulated across severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome. They have observed that the positively-selected mutations in the viral spike S1 subunit are primarily responsible for adaptive evolution. This indicates that the virus may undergo antigenic drift.

23 Mar 2022

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Researchers discuss alternate therapeutic targets for treating COVID-19 and the effects of Gal-9 on SARS-CoV-2 infection and the immune response.

23 Mar 2022

Researcher wins three NIH grants to tackle mosquito-borne viruses

West Nile virus, Usutu virus, Zika virus, and St. Louis encephalitis virus are all transmitted by mosquitoes and cause a significant threat to human health.

23 Mar 2022

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

There is likely recombination of genome sequences between the SARS-CoV-2 Delta and Omicron variants in their spike (S) protein.

23 Mar 2022

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use.

23 Mar 2022

INTEGRA’s ASSIST PLUS pipetting robot helps to streamline sample pooling for arbovirus testing

INTEGRA Biosciences’ ASSIST PLUS pipetting robot is helping the Arbovirus Testing Lab at the New Hampshire Public Health Laboratories in Concord, USA, to streamline sample pooling for West Nile and Eastern equine encephalitis virus testing.

From INTEGRA Biosciences 23 Mar 2022

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

New York Blood Center’s Project ACHIEVE and Columbia University’s Columbia Research Unit are working in partnership for the New York City effort to advance the use of messenger ribonucleic acid (mRNA) technology in an HIV preventive vaccine study – HVTN 302.

23 Mar 2022

Study shows link between psychotropic medication use and post-Covid dementia

Recent studies have highlighted the connection between coronavirus disease 2019 (COVID-19) infection and the development of dementia.

23 Mar 2022

Seafood workers twice as likely to contract COVID-19 as workers in other food industries

The dramatic toll that COVID-19 has taken on the U.S. is apparent, but as caseloads come down and mandates are loosened it has become increasingly obvious how much of an impact the pandemic had on food service workers in industries like the fisheries.

23 Mar 2022

Virus News and Research

Latest Virus News and Research

Breast milk components show potent in vitro SARS-CoV-2 inhibition

New implantable biotechnology produces and releases CAR-T cells for attacking tumors

U of A researcher receives $436,642 from NIH to study effects of SARS-COV-2 on the aortic valve

Polio vaccination campaign kicks off in Malawi and neighboring countries

UB-612 vaccine booster found to elicit high neutralizing antibody levels against SARS-CoV-2 Omicron

Study explores favorable signatures for specific RNA motif recognition by SARS-CoV-2 nucleocapsid

New SARS-CoV-2 Omicron-Delta recombinant virus identified in the US

Study evaluates mutation-induced SARS-CoV-2 spike protein fold stability

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

Study evaluates the prevalence of autoantibodies targeting type I interferons in critically-ill COVID-19 patients

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Researcher wins three NIH grants to tackle mosquito-borne viruses

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

INTEGRA’s ASSIST PLUS pipetting robot helps to streamline sample pooling for arbovirus testing

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

Study shows link between psychotropic medication use and post-Covid dementia

Seafood workers twice as likely to contract COVID-19 as workers in other food industries

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in